v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue $ 0 $ 257
Operating expenses:    
Research and development 12,351 5,141
Selling, general and administrative 4,588 3,726
Total operating expenses 16,939 8,867
Loss from operations (16,939) (8,610)
Other (income) expense:    
Amortization of debt issuance costs and discount 0 312
Interest income (535) (776)
Interest expense 0 173
Other income (354) 0
Warrant liabilities fair value adjustment 5,249 (2,928)
Total other expense (income) 4,360 (3,219)
Net loss $ (21,299) $ (5,391)
Net loss per share - basic $ (0.42) $ (0.11)
Net loss per share - diluted $ (0.42) $ (0.11)
Weighted average common shares outstanding - basic 50,957,191 49,435,500
Weighted average common shares outstanding - diluted 50,957,191 49,435,500
License Agreement Revenue    
Revenue:    
Total revenue $ 0 $ 257